Publications by authors named "V Foy"

Many dermatologic medications have the potential to induce ocular complications. Traditional medications, including corticosteroids, retinoids, antibiotics, antihistamines, and immunosuppressants, have been associated with eye dryness, irritation, allergy, infection, atrophy, pigmentary changes, increased intraocular pressure, and impaired vision. Novel therapeutic agents such as biologics raise new concerns for ocular surface disease and conjunctivitis.

View Article and Find Full Text PDF

Biliary tract cancers (BTCs) are aggressive in nature, often presenting asymptomatically until they are diagnosed at an advanced stage. Surgical resection or liver transplantation are potential curative options. However, a large proportion of patients present with incurable locally advanced or metastatic disease and most of these patients are only eligible for palliative chemotherapy or best supportive care.

View Article and Find Full Text PDF
Article Synopsis
  • Pancreatic ductal adenocarcinoma (PDAC) is a major cause of cancer-related deaths with increasing cases worldwide, but it's challenging to screen due to few strong predictive risk factors.
  • The NAPOLI-3 trial suggests NALIRIFOX as a potential new first-line treatment, as current therapies heavily rely on cytotoxic chemotherapy.
  • Promising developments in targeting KRAS G12D mutations and combining immunotherapy with chemotherapy could lead to more effective treatments for PDAC.
View Article and Find Full Text PDF
Article Synopsis
  • Atopic dermatitis (AD) is a long-lasting skin condition that can start in childhood and continue into adulthood, or emerge for the first time in adults.
  • A study was conducted to compare the clinical characteristics of adults with either pediatric-onset or adult-onset AD using medical records from a large academic center.
  • Results showed that adults with adult-onset AD had different signs and symptoms compared to those with pediatric-onset AD, suggesting that current diagnostic criteria may not fully recognize adult-onset AD, potentially leading to underdiagnosis.
View Article and Find Full Text PDF